EEF2K and neoplasm: We observed that (1) in the HPA COAD cohort, lower eEF2K expression is associated with improved survival outcomes, consistent with our observations from the TCGA cohort; (2) in the HPA BRCA cohort, we observed high eEF2K mRNA expression levels in the tumor samples, consistent with the TCGA BRCA cohort.